Le Lézard
Classified in: Health, Science and technology
Subject: PLW

EyeLock Granted Patent For A Single Camera System For Acquiring Iris Biometrics And Face Images


NEW YORK, May 9, 2017 /PRNewswire/ -- EyeLock LLC, a leader of iris-based identity authentication solutions, today announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 9,646,217 that enables a single camera to acquire iris biometrics as well as a face image by providing suitable illumination adjustments between the two acquisitions. 

"Our latest patent continues to strengthen EyeLock's position in the mobile and broader Internet of Things (IoT) sectors," said Jim Demitrieus, CEO of EyeLock. "The compact design of this solution leverages a single camera component to perform multiple functions, resulting in a lower total cost to Original Equipment Manufacturers (OEMs) and increased capabilities for end-users."

Mr. Demitrieus noted that this invention:

This patent is the most recent example of how EyeLock has achieved significant technological breakthroughs and solved integration challenges that have historically been a barrier to mass-market adoption of iris authentication technology. In addition, the Company's approach provides maximum flexibility by offering designs that have either on-board or host-based processing and illumination. Algorithm performance capabilities for speed and accuracy have been validated by Novetta, a leader in advanced analytics technology and independent biometric testing, as unmatched in the market. The EyeLock reference designs have working distances of up to 60 cm with a false accept rate of 1 in 1.5 million for single eye authentication and a false reject rate of less than 1%.

About EyeLock

EyeLock LLC, a majority owned subsidiary of Voxx International Corporation (NASDAQ: VOXX), is an acknowledged leader in advanced iris authentication for the Internet of Things (IoT), providing the highest level of security with EyeLock IDtm technology. Iris authentication is highly secure because no two irises are alike and the iris is the most accurate human identifier other than DNA. The company's significant IP portfolio, including more than 100 patents and patents pending, and proprietary technology enables the convenient and secure authentication of individuals across physical and logical environments. EyeLock's solutions have been integrated and embedded across consumer and enterprise products and platforms, eliminating the need for PINs and passwords. Corporations across the Fortune 500 recognize the level of security EyeLock provides due in part to its extremely low false acceptance rate, ease of use, and scalability. As a sponsor member of the FIDO (Fast IDentity Online) Alliance, a non-profit organization dedicated to creating a safer and more secure digital presence for consumers, EyeLock is dedicated to advancing digital privacy and next generation security. For more information, please visit www.eyelock.com.

CONTACT:
Brian Levine
Game 7 Comms
561-866-9291
[email protected]

SOURCE EyeLock LLC


These press releases may also interest you

25 avr 2024
The report titled "Anti-Adhesion Products Market by Product Type (Natural Adhesion Barriers, Synthetic Adhesion Barriers), Product Form (Film Formulation, Gel Formulation, Liquid Formulation), Application, End-User - Global Forecast 2024-2030" is now...

25 avr 2024
Product: Meat and vegetable products Issue: Food - Microbial Contamination - Listeria Distribution:British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

25 avr 2024
The report titled "Contract Research Organization Services Market by Type (Clinical Research Services, Consulting Services, Data Management Services), Trial Phase (Phase I, Phase II, Phase III), Therapeutic Area, Molecule Type, End-User - Global...

25 avr 2024
Greenbrook TMS Inc. ("Greenbrook" or the "Company") today announced its fiscal year ended December 31, 2023 ("Fiscal 2023") operational and financial results. All values in this news release are in United States dollars, unless otherwise stated....

25 avr 2024
AIDS Healthcare Foundation applauds the government of Colombia for issuing a compulsory license on HIV drug dolutegravir, which will allow the country to access affordable generic versions of the treatment as an alternative to the costly branded...

25 avr 2024
BCACC is pleased to announce that its Deputy Registrar, Kathy Lauriente, has been honoured with the Distinguished Service Award from Thompson Rivers University. The award recognizes stellar contributions to the University, community, and the public...



News published on and distributed by: